Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 318

1.

TDP-43 and pathological subtype of Alzheimer's disease impact clinical features.

Josephs KA, Whitwell JL, Tosakulwong N, Weigand SD, Murray ME, Serie AM, Petrucelli L, Senjem ML, Ivnik RJ, Parisi JE, Petersen RC, Dickson DW.

Ann Neurol. 2015 Jul 29. doi: 10.1002/ana.24493. [Epub ahead of print]

PMID:
26224156
2.

Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer's disease.

Gungor I, Sarro L, Graff-Radford J, Zuk SM, Tosakulwong N, Przybelski SA, Lesnick T, Boeve BF, Ferman TJ, Smith GE, Knopman DS, Filippi M, Petersen RC, Jack CR Jr, Kantarci K.

Parkinsonism Relat Disord. 2015 Jul 14. pii: S1353-8020(15)00293-X. doi: 10.1016/j.parkreldis.2015.07.008. [Epub ahead of print]

PMID:
26205074
3.

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, Thompson PM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):865-84. doi: 10.1016/j.jalz.2015.04.005. Review.

PMID:
26194320
4.

The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.

Kang JH, Korecka M, Figurski MJ, Toledo JB, Blennow K, Zetterberg H, Waligorska T, Brylska M, Fields L, Shah N, Soares H, Dean RA, Vanderstichele H, Petersen RC, Aisen PS, Saykin AJ, Weiner MW, Trojanowski JQ, Shaw LM; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):772-91. doi: 10.1016/j.jalz.2015.05.003. Review.

PMID:
26194312
5.

Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans.

Aisen PS, Petersen RC, Donohue M, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):734-9. doi: 10.1016/j.jalz.2015.05.005. Review.

PMID:
26194309
6.

Age and Education Corrected Older Adult Normative Data for a Short Form Version of the Financial Capacity Instrument.

Gerstenecker A, Eakin A, Triebel K, Martin R, Swenson-Dravis D, Petersen RC, Marson D.

Psychol Assess. 2015 Jul 13. [Epub ahead of print]

PMID:
26168311
7.

Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study.

Østergaard SD, Mukherjee S, Sharp SJ, Proitsi P, Lotta LA, Day F, Perry JR, Boehme KL, Walter S, Kauwe JS, Gibbons LE; Alzheimer’s Disease Genetics Consortium; GERAD1 Consortium; EPIC-InterAct Consortium, Larson EB, Powell JF, Langenberg C, Crane PK, Wareham NJ, Scott RA.

PLoS Med. 2015 Jun 16;12(6):e1001841; discussion e1001841. doi: 10.1371/journal.pmed.1001841. eCollection 2015 Jun.

8.

Sample size calculations for clinical trials targeting tauopathies: a new potential disease target.

Whitwell JL, Duffy JR, Strand EA, Machulda MM, Tosakulwong N, Weigand SD, Senjem ML, Spychalla AJ, Gunter JL, Petersen RC, Jack CR Jr, Josephs KA.

J Neurol. 2015 Jun 17. [Epub ahead of print]

PMID:
26076744
9.

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Green RC, Harvey D, Jack CR, Jagust W, Luthman J, Morris JC, Petersen RC, Saykin AJ, Shaw L, Shen L, Schwarz A, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jun;11(6):e1-e120. doi: 10.1016/j.jalz.2014.11.001.

PMID:
26073027
10.

Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease.

Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Kapogiannis D.

Neurology. 2015 Jul 7;85(1):40-7. doi: 10.1212/WNL.0000000000001702. Epub 2015 Jun 10.

PMID:
26062630
11.

APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern.

Risacher SL, Kim S, Nho K, Foroud T, Shen L, Petersen RC, Jack CR Jr, Beckett LA, Aisen PS, Koeppe RA, Jagust WJ, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Alzheimers Dement. 2015 May 7. pii: S1552-5260(15)00124-7. doi: 10.1016/j.jalz.2015.03.003. [Epub ahead of print]

PMID:
25960448
12.

Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease.

Pottier C, Bieniek KF, Finch N, van de Vorst M, Baker M, Perkersen R, Brown P, Ravenscroft T, van Blitterswijk M, Nicholson AM, DeTure M, Knopman DS, Josephs KA, Parisi JE, Petersen RC, Boylan KB, Boeve BF, Graff-Radford NR, Veltman JA, Gilissen C, Murray ME, Dickson DW, Rademakers R.

Acta Neuropathol. 2015 Jul;130(1):77-92. doi: 10.1007/s00401-015-1436-x. Epub 2015 May 6.

PMID:
25943890
13.

New criteria for Alzheimer's disease: which, when and why?

Schott JM, Petersen RC.

Brain. 2015 May;138(Pt 5):1134-7. doi: 10.1093/brain/awv055. No abstract available.

PMID:
25907755
14.

Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer's pathophysiology and susceptibility.

Sevlever D, Zou F, Ma L, Carrasquillo S, Crump MG, Culley OJ, Hunter TA, Bisceglio GD, Younkin L, Allen M, Carrasquillo MM, Sando SB, Aasly JO, Dickson DW, Graff-Radford NR, Petersen RC; Kevin Morgan for ARUK consortium, Belbin O.

Mol Neurodegener. 2015 Apr 9;10:18. doi: 10.1186/s13024-015-0015-x.

15.

White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging.

Nedelska Z, Schwarz CG, Boeve BF, Lowe VJ, Reid RI, Przybelski SA, Lesnick TG, Gunter JL, Senjem ML, Ferman TJ, Smith GE, Geda YE, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K.

Neurobiol Aging. 2015 Jun;36(6):2010-7. doi: 10.1016/j.neurobiolaging.2015.03.007. Epub 2015 Mar 14.

PMID:
25863527
16.

Performance of the CogState computerized battery in the Mayo Clinic Study on Aging.

Mielke MM, Machulda MM, Hagen CE, Edwards KK, Roberts RO, Pankratz VS, Knopman DS, Jack CR Jr, Petersen RC.

Alzheimers Dement. 2015 Apr 6. pii: S1552-5260(15)00086-2. doi: 10.1016/j.jalz.2015.01.008. [Epub ahead of print]

PMID:
25858683
17.

Direct medical costs and source of cost differences across the spectrum of cognitive decline: A population-based study.

Leibson CL, Long KH, Ransom JE, Roberts RO, Hass SL, Duhig AM, Smith CY, Emerson JA, Pankratz VS, Petersen RC.

Alzheimers Dement. 2015 Apr 6. pii: S1552-5260(15)00085-0. doi: 10.1016/j.jalz.2015.01.007. [Epub ahead of print]

PMID:
25858682
18.

Risk and protective factors for cognitive impairment in persons aged 85 years and older.

Roberts RO, Cha RH, Mielke MM, Geda YE, Boeve BF, Machulda MM, Knopman DS, Petersen RC.

Neurology. 2015 May 5;84(18):1854-61. doi: 10.1212/WNL.0000000000001537. Epub 2015 Apr 8.

PMID:
25854867
19.

The Human Alzheimer Disease Project: A New Call to Arms.

Rosenberg RN, Petersen RC.

JAMA Neurol. 2015 Jun 1;72(6):626-8. doi: 10.1001/jamaneurol.2015.67. No abstract available.

PMID:
25844883
20.

Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.

Murray ME, Lowe VJ, Graff-Radford NR, Liesinger AM, Cannon A, Przybelski SA, Rawal B, Parisi JE, Petersen RC, Kantarci K, Ross OA, Duara R, Knopman DS, Jack CR Jr, Dickson DW.

Brain. 2015 May;138(Pt 5):1370-81. doi: 10.1093/brain/awv050. Epub 2015 Mar 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk